Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell Banks, Pharmaceutical Companies) - Global Forecast to 2019

Publisher Name :
Date: 11-May-2015
No. of pages: 175
Inquire Before Buying

The global mycoplasma testing market is expected to reach $613.49 million by 2019 from $340.29 million in 2014, growing at a CAGR of 12.51% between 2014 and 2019. The mycoplasma testing product segments included in this report are instruments, kits & reagents, and services. The kits & reagents segment is further divided on the basis of type into stains, elimination kits, PCR assays, nucleic acid detection kits, standards & controls and other kits & reagents.The technology segments included are microbial culture techniques, DNA staining, PCR, ELISA, direct assay, indirect assay and enzymatic methods. On the basis of applications, the report is segmented into cell line testing, virus testing, end of production cells testing and other applications. The cell line testing applications had the largest share of the mycoplasma testing market in 2014. The cell line testing application is expected to be one of the fastest growing applications between 2014 and 2019.

The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global mycoplasma testing market in 2014.Asia regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing demand for mycoplasma testing and drug discovery and research from this region.

The key driver for this market is increased research funding by government. Furthermore, growing biotechnology and pharmaceutical companies to increase R&D activities and innovations in life science researchand will aid the growth of the global mycoplasma testing market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global mycoplasma testing market and its sub-segments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their mycoplasma testing product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the mycoplasma testing market. The competitive landscape covers the growth strategies adopted by the industry players over the last four years. It also includes analysis of industry developments like expansions, agreements and partnerships, mergers and acquisitions and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:


  • Product Development:Product portfolios of the top players in the mycoplasma testing market.

  • Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the mycoplasma testing market.

  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various mycoplasma testingproducts across geographies.

Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell Banks, Pharmaceutical Companies) - Global Forecast to 2019

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Mycoplasma Testing Market to Grow at A High Rate
4.2 Life Cycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Mycoplasma Testing Market, By Product
5.2.2 Mycoplasma Testing Market, By Technology
5.2.3 Mycoplasma Testing Market, By Application
5.2.4 Mycoplasma Testing Market, By Enduser
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rapid Growth in Pharmaceutical and Biotechnology Industries
5.3.1.2 Strong Trend of R&D Investments in Life Sciences
5.3.1.3 Increasing Government Support for Pharmaceutical and Biotechnology Industries
5.3.2 Restraints
5.3.2.1 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
5.3.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
5.3.3 Opportunities
5.3.3.1 Increasing Pharmaceutical Outsourcing

6 Industry Insights
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat From Substitutes
6.2.3 Bargaining Power of Buyers
6.2.4 Bargaining Power of Suppliers
6.2.5 Competitive Rivalry Among Existing Players
6.3 Strategic Benchmarking
6.3.1 Agreements, Collaborations, and Partnerships
6.4 Supply Chain Analysis
6.4.1 Key Influencers

7 Mycoplasma Testing Market, By Product
7.1 Introduction
7.2 KITS & Reagents
7.2.1 PCR Assays
7.2.2 Nucleic Acid Detection KITS
7.2.3 Elimination KITS& Reagents
7.2.4 Stains
7.2.5 Standards & Controls
7.2.6 Others KITS & Reagents
7.3 Instruments
7.4 Services

8 Mycoplasma Testing Market, By Technology
8.1 Introduction
8.2 PCR
8.3 Elisa
8.4 Direct Assay
8.5 Indirect Assay
8.6 Dna Staining
8.7 Microbial Culture Techniques
8.8 Enzymatic Methods

9 Mycoplasma Testing Market, By Application
9.1 Introduction
9.2 Cell Line Testing
9.3 Virus Testing
9.4 End of Production Cells Testing
9.5 Other Applications

10 Mycoplasma Testing Market, By End User
10.1 Introduction
10.2 Pharmaceutical and Biotechnology Companies
10.3 Contract Research Organizations
10.4 Academic Research Institutes
10.5 Cell Banks
10.6 Other End Users

11 Geographic Analysis
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.4 Asia
11.5 Rest of the World (RoW)

12 Competitive Landscape
12.1 Introduction
12.2 Market Share Analysis, Mycoplasma Testing Market
12.3 Competitive Situation and Trends
12.3.1 Agreements, Collaborations and Partnerships
12.3.2 Expansion
12.3.3 Acquisitions
12.3.4 New Product and Service Launches
12.3.5 Other Strategies

13 Company Profiles
13.1 Introduction
13.2 Charles River Laboratories International, Inc.
13.2.1 Business Overview
13.2.2 Products & Services
13.2.3 Recent Developments
13.2.4 MNM View
13.2.4.1 Financial Analysis
13.2.4.2 Strategic Analysis
13.3 Lonza Group Ltd.
13.3.1 Business Overview
13.3.2 Products & Services
13.3.3 Recent Developments
13.3.4 MNM View
13.3.4.1 Financial Analysis
13.3.4.2 Strategic Analysis
13.4 Merck & Co., Inc.
13.4.1 Business Overview
13.4.2 Product Portfolio
13.4.3 Recent Developments
13.4.4 MNM View
13.4.4.1 Financial Analysis
13.4.4.2 Strategic Analysis
13.5 Sigma-Aldrich Corporation
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Recent Developments
13.5.4 MNM View
13.5.4.1 Financial Analysis
13.5.4.2 Strategic Analysis
13.6 Thermo Fisher Scientific, Inc.
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Recent Developments
13.6.4 MNM View
13.6.4.1 Financial Analysis
13.6.4.2 Strategic Analysis
13.7 American Type Culture Collection
13.7.1 Business Overview
13.7.2 Products & Services
13.7.3 Recent Developments
13.7.4 Key Strategy
13.8 Biological Industries Israel Beit Haemek Ltd.
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Key Strategy
13.9 Bionique Testing Laboratories, Inc.
13.9.1 Business Overview
13.9.2 Products & Services
13.9.3 Key Strategy
13.10 Invivogen
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Key Strategy
13.11 Promo Cell GMBH
13.11.1 Product Portfolio
13.11.2 Key Strategy

14 Appendix
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Introducing RT: Real Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports

List of Tables

Table 1 Mycoplasma Testing Market Summary
Table 2 Rapid Growth in the Pharmaceutical and Biotechnology Industries is Propelling the Growth of Mycoplasma Testing Market
Table 3 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
Table 4 Increasing Pharmaceutical Outsourcing are Paving New Growth Avenues for Players in the Mycoplasma Testing Market
Table 5 Market Developments Between 2011 and 2015
Table 6 Market Size, By Product, 2012–2019 ($Million)
Table 7 Mycoplasma Testing KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 8 Mycoplasma Testing KITS & Reagents Market Size, By Region, 2012–2019 ($Million)
Table 9 PCR Assay Market Size, By Region, 2012–2019 ($Million)
Table 10 Nucleic Acid Detection KITS Market Size, By Region, 2012–2019 ($Million)
Table 11 North America Commanded the Largest Share of Eliminations KITS & Reagents Segment in 2014
Table 12 Eliminations KITS & Reagents Market Size, By Region, 2012–2019 ($Million)
Table 13 Mycoplasma Testing Stains Market Size, By Region, 2012–2019 ($Million)
Table 14 Standards & Controls Market Size, By Region, 2012–2019 ($Million)
Table 15 Other KITS & Reagents Market Size, By Region, 2012–2019 ($Million)
Table 16 Mycoplasma Testing Instruments Market Size, By Region, 2012–2019 ($Million)
Table 17 Mycoplasma Testing Services Market Size, By Region, 2012–2019 ($Million)
Table 18 Mycoplasma Testing Market Size, By Technology, 2012–2019 ($Million)
Table 19 PCR Method Market Size, By Region, 2012–2019 ($Million)
Table 20 Elisa Method Market Size, By Region, 2012–2019 ($Million)
Table 21 Direct Assay Market Size, By Region, 2012–2019 ($Million)
Table 22 Indirect Assay Market Size, By Region, 2012–2019 ($Million)
Table 23 North America Dominated the Largest Share of the DNA Staining Technology Segment in 2014
Table 24 DNA Staining Market Size, By Region, 2012–2019 ($Million)
Table 25 Microbial Culture Techniques Market Size, By Region, 2012–2019 ($Million)
Table 26 Enzymatic Methods Market Size, By Region, 2012–2019 ($Million)
Table 27 Mycoplasma Testing Market Size, By Application, 2012–2019 ($Million)
Table 28  Market Size for Cell Line Testing, By Region, 2012–2019 ($Million)
Table 29 Market Size for Virus Testing, By Region, 2012–2019 ($Million)
Table 30 Market Size for End of Production Cells Testing Applications, By Region, 2012–2019 ($Million)
Table 31 Mycoplasma Testing Market Size for Other Applications, By Region, 2012–2019 ($Million)
Table 32  Market Size, By End User, 2012–2019 ($Million)
Table 33 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2012–2019 ($Million)
Table 34 Mycoplasma Testing Market Size for Contract Research Organizations, By Region, 2012–2019 ($Million)
Table 35 Market Size for Academic Research Institutes, By Region, 2012–2019 ($Million)
Table 36 Market Size for Cell Banks, By Region, 2012–2019 ($Million)
Table 37 Market Size for Other End Users, By Region, 2012–2019 ($Million)
Table 38 Market Size, By Region, 2012–2019 ($Million)
Table 39 North America: Mycoplasma Testing Market Size, By Country, 2012–2019 ($Million)
Table 40 North America:  Market Size, By Product, 2012–2019 ($Million)
Table 41 North America: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 42 North America:  Market Size, By Technology, 2012–2019 ($Million)
Table 43 North America: Market Size, By Application, 2012–2019 ($Million)
Table 44 North America: Market Size, By End User, 2012–2019 ($Million)
Table 45 U.S.: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 46 U.S.: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 47 U.S.: Market Size, By Technology, 2012–2019 ($Million)
Table 48 U.S.:  Market Size, By Application, 2012–2019 ($Million)
Table 49 U.S.:  Market Size, By End User, 2012–2019 ($Million)
Table 50 Canada: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 51 Canada: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 52 Canada: Market Size, By Technology, 2012–2019 ($Million)
Table 53 Canada: Market Size, By Application, 2012–2019 ($Million)
Table 54 Canada: Market Size, By End User, 2012–2019 ($Million)
Table 55 Europe: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 56 Europe: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 57 Europe: Market Size, By Technology, 2012–2019 ($Million)
Table 58 Europe:  Market Size, By Application, 2012–2019 ($Million)
Table 59 Europe:  Market Size, By End User, 2012–2019 ($Million)
Table 60 Asia: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 61 Asia: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 62 Asia: Market Size, By Technology, 2012–2019 ($Million)
Table 63 Asia:  Market Size, By Application, 2012–2019 ($Million)
Table 64 Asia: Market Size, By End User, 2012–2019 ($Million)
Table 65 RoW: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 66 RoW: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 67 RoW:  Market Size, By Technology, 2012–2019 ($Million)
Table 68 RoW: Market Size, By Application, 2012–2019 ($Million)
Table 69 RoW:  Market Size, By End User, 2012–2019 ($Million)
Table 70 Agreements, Collaborations and Partnerships, 2011–2015
Table 71 Expansions, 2011–2015
Table 72 Acquisitions, 2011–2015
Table 73 New Product & Service Launches, 2011–2015
Table 74 Other Development, 2011–2015

List of Figures

Figure 1 Global Mycoplasma Testing Market
Figure 2 Research Methodology
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Mycoplasma Testing Market Size, By Product, 2014 ($Million)
Figure 8 Market Size, KITS & Reagents By Type, 2014 ($Million)
Figure 9  Market Size, By Technology, 2014 ($Million)
Figure 10 Market Size, By Application, 2014 ($Million)
Figure 11 Market Size, By End User, 2014 ($Million)
Figure 12 Market Size, By Geography, 2014 ($Million)
Figure 13 Increasing Research and Development Activities and Pharmaceutical Outsourcing are Important Growth Drivers
Figure 14 KITS & Reagents to Dominate the Mycoplasma Testing Market
Figure 15 Asia to Grow at the Highest Rate During the Forecast Period
Figure 16 Asian Market Showcases Lucrative Growth Opportunities
Figure 17 Market Segmentation: By Product
Figure 18 Market Segmentation: By Technology
Figure 19 Market Segmentation: By Application
Figure 20 Market Segmentation: By End User
Figure 21 Growth in Pharmaceutical and Biotechnology Industries Will Drive the Mycoplasma Testing Market
Figure 22 Increasing R&D Investments is an Important Driver for this Market
Figure 23 Porter’s Five Forces Analysis
Figure 24 Major Players Adopted the Inorganic Growth Strategy of Agreements, Collaborations, & Partnerships Between 2011 & 2014
Figure 25 Supply Chain Analysis
Figure 26 Mycoplasma Testing Market, By Product
Figure 27 KITS & Reagents Commanded the Largest Share of Mycoplasma Testing Market in 2014
Figure 28 Mycoplasma Testing KITS & Reagents Market, By Type
Figure 29 PCR Assays Commanded the Largest Share of KITS & Reagents in 2014
Figure 30 Asia to Be the Fastest Growing Segment of the KITS & Reagents Market in the Frocast Period
Figure 31 North America Commanded the Largest Share of PCR Assays Segment in 2014
Figure 32 Asia to Be the Fastest Growing Segment of Nucleic Acid Detection KITS Market in the Forecast Period
Figure 33 Asia to Be the Fastest Growing Segment of the Stains Market in the Forecast Period
Figure 34 North America Commanded the Largest Share of Standards & Controls Segment in 2014
Figure 35 Asia to Be the Fastest Growing Segment of the of Other KITS & Reagents Market in the Forecast Period
Figure 36 North America Commanded the Largest Share of Instruments Segment in 2014
Figure 37 Asia to Be the Fastest Growing Segment of the Services Market in the Forecast Period
Figure 38 Global Mycoplasma Testing Market, By Technology
Figure 39 PCR Will Be the Largest Application Segment in Global Mycoplasma Testing Market
Figure 40 North America Dominated the Largest Share of the PCR Technology Segment in 2014
Figure 41 North America Dominated the Largest Share of the Elisa Technology Segment in 2014
Figure 42 North America Dominated the Largest Share of the Direct Assay Technology Segment in 2014
Figure 43 North America Dominated the Largest Share of the Indirect Assay Technology Segment in 2014
Figure 44 North America Dominated the Largest Share of the Microbial Culture Techniques Technology Segment in 2014
Figure 45 North America Dominated the Largest Share of the Enzymatic Methods Technology Segment in 2014
Figure 46 Mycoplasma Testing Market Segmentation, By Application
Figure 47 Cell Line Testing Will Be the Fastest-Growing Application Segment
Figure 48 North America Commanded the Largest Share of the Cell Line Testing Segment in 2014
Figure 49 North America Dominated the Virus Testing Segment in 2014
Figure 50 Asian Market for the End of Production Cells Testing Market to Grow at the Highest CAGR
Figure 51 North America Held the Largest Share of the Other Applications Segment in 2014
Figure 52 Mycoplasma Testing Market Segmentation, By End User
Figure 53 Market Size, By End User, 2014 vs. 2019 ($Million)
Figure 54 Large Number of Granted Patents Enhancing Growth of the Pharmaceutical & Biotechnology Companies Segment
Figure 55 North America Commanded the Largest Share of the Pharmaceutical and Biotechnology Companies Segment in 2014
Figure 56 North America Commanded the Largest Share of the Contract Research Organizations End-User Segment in 2014
Figure 57 Public Sector Research Funding is Driving the Growth of the Academic Research Institutes Segment
Figure 58 Asian Mycoplasma Testing Market for Academic Research Institutes to Grow at Highest Rate in the Forecast Period
Figure 59 North America Commanded the Largest Share of the Cell Banks Segment in 2014
Figure 60 Asian Mycoplasma Testing Market for Other End Users to Grow at Highest Rate in the Forecast Period
Figure 61 Geographic Snapshot (2014)
Figure 62 Mycoplasma Testing Market, By Region CAGR 2014, Asia to Grow at the Highest Rate During the Forecast Period
Figure 63 North America: Mycoplasma Testing Market Size, By Country CAGR 2014, U.S. to Grow at A Faster Rate in the Forecast Period
Figure 64 North America: Market Snapshot(2014-2019): Availability of Life Science Research Funding is Driving the Market Growth
Figure 65 KITS & Reagents are Estimated to Be the Largest Product Segment in North America Mycoplasma Testing Market in 2014
Figure 66 North America: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 67 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in North America
Figure 68 North America: Mycoplasma Testing Market Size, By Application (Market Size), 2014 vs. 2019
Figure 69 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in North America
Figure 70 KITS & Reagents are Estimated to Be the Largest Product Segment in U.S. in 2014
Figure 71 U.S.: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 72 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in U.S.
Figure 73 U.S.: Mycoplasma Testing Market Size, By Application (Market Size), 2014 vs. 2019
Figure 74 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in U.S.
Figure 75 KITS & Reagents are Estimated to Be the Largest Product Segment in Canada in 2014
Figure 76 Canada: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 77 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in Canada
Figure 78 Canada: Mycoplasma Testing Market Size, By Application (Market Size), 2014 vs. 2019
Figure 79 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in Canada
Figure 80 KITS & Reagents are Estimated to Be the Largest Product Segment in Europe in 2014
Figure 81 PCR Assays are Estimated to Be the Largest Segment in KITS & Reagents Market in Europe in 2014
Figure 82 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in Europe
Figure 83 Europe: Mycoplasma Testing Market Size, By Application (Market Size and Growth Rate), 2014 vs. 2019
Figure 84 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in Europe
Figure 85 KITS & Reagents are Estimated to Be the Largest Product Segment in Asia in 2014
Figure 86 Asia: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 87 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in Asia
Figure 88 Asia: Market Size, By Application (Market Size and Growth Rate), 2014 vs. 2019
Figure 89 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in Asia
Figure 90 KITS & Reagents are Estimated to Be the Largest Product Segment in RoW in 2014
Figure 91 RoW: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 92 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in RoW
Figure 93 RoW: Market Size, By Application (Market Size), 2014 vs. 2019
Figure 94 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in RoW
Figure 95 Agreements, Collaborations, and Partnerships are Key Strategies Adopted By Players in this Market
Figure 96 Global Mycoplasma Testing Market Share Analysis, By Key Players, 2014
Figure 97 Competitive Situation and Trends: Agreements, Collaborations & Partnerships are the Key Growth Strategies
Figure 98 Financial Performances of the Leading Market Players
Figure 99 Company Snapshot: Charles River Laboratories International, Inc.
Figure 100 Company Snapshot: Lonza Group Ltd.
Figure 101 Company Snapshot: Merck & Co., Inc.
Figure 102 Company Snapshot: Sigma-Aldrich Corporation
Figure 103 Company Snapshot: Thermo Fisher Scientific, Inc.

  • 2017-2022 Biomedical Nanotechnology Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 29-Mar-2017        Price: US 2960 Onwards        Pages: 126
    This report studies the Biomedical Nanotechnology market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Biomedical Nanotechnology market by product type and applications/end industries. The global Biomedical Nanotechnology market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, gro......
  • Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021
    Published: 29-Mar-2017        Price: US 5650 Onwards        Pages: 139
    The global downstream processing market is projected to reach USD 22.03 billion by 2021 from USD 10.32 billion in 2016, at a CAGR of 16.4% from 2016 to 2021.Increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry are the major factors driving the growth of the global downstream processing market. Developing markets in Asia-Pacific such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore are lucrative markets for d......
  • 2017-2022 China Human Micobiome Market Report (Status and Outlook)
    Published: 27-Mar-2017        Price: US 3360 Onwards        Pages: 113
    The Human Micobiome market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as - Vedanta - Seres Therapeutics - Second Genome - Rebiotix - ActoGeniX - Enterome BioScience - AvidBiotics - 4D P......
  • 2017-2022 Global Top Countries Human Micobiome Market Report
    Published: 24-Mar-2017        Price: US 4960 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." This report studies Human Micobiome in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering - Vedanta - Seres Therapeutics - Second Genome - Rebiotix - ActoG......
  • 2017-2022 Japan Human Micobiome Market Report (Status and Outlook)
    Published: 24-Mar-2017        Price: US 3360 Onwards        Pages: 113
    "This report will be delivered in 2-3 business days after the order is placed." The Human Micobiome market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as - Vedanta - Seres Therapeutics - Se......
  • 2017-2022 UK Human Micobiome Market Report (Status and Outlook)
    Published: 24-Mar-2017        Price: US 3360 Onwards        Pages: 113
    "This report will be delivered in 2-3 business days after the order is placed." The Human Micobiome market size will be XX million (USD) in 2022 in UK, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In UK market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as - Vedanta - Seres Therapeutics - Second G......
  • 2017-2022 United States Human Micobiome Market Report (Status and Outlook)
    Published: 23-Mar-2017        Price: US 3360 Onwards        Pages: 113
    "This report will be delivered in 2-3 business days after the order is placed." The Human Micobiome market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as - Vedanta - Seres Therapeu......
  • 2017 Top 5 Human Micobiome Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 23-Mar-2017        Price: US 4960 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." This report studies Human Micobiome in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Human Micobiome Players in each region, with sales, price, revenue and market share for top 5 manufacturer, covering - Vedanta - Seres Therapeutics - Second Genome - Rebiotix - ActoGeniX......
  • 2017-2022 Germany Human Micobiome Market Report (Status and Outlook)
    Published: 23-Mar-2017        Price: US 3360 Onwards        Pages: 113
    "This report will be delivered in 2-3 business days after the order is placed." The Human Micobiome market size will be XX million (USD) in 2022 in Germany, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Germany market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as - Vedanta - Seres Therapeutics ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs